A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5455-5463

  Schwendinger, Michael G ^a   Spruth, Martin ^a   Schoch, Jürgen ^a   Dierich, Manfred P ^a   Prodinger, Wolfgang M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL LINE; COMPLEMENT ACTIVATION; IMMUNOLOGY; SIGNAL TRANSDUCTION;

B-LYMPHOCYTES; CELL LINE; COMPLEMENT ACTIVATION; COMPLEMENT C3; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION;

EID: 0031154649     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cooper, N. R., M. D. Moore, and G. R. Nemerow. 1988. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu. Rev. Immunol. 6:85.
2. Ahearn, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
3. Ross, G. D., M. J. Polley, E. M. Rabellino, and H. M. Grey. 1973. Two different complement receptors on human lymphocytes: one specific for C3b and one specific for C3b inactivator cleaved C3b. J. Exp. Med. 138:798.
4. Weis, J. J., T. F. Tedder, and D. T. Fearon. 1984. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81:881.
5. Iida, K., L. Nadler, and V. Nussenzweig. 1983. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158:1021.
6. Fischer, E., C. Delibrias, and M. D. Kazatchkine. 1991. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146:865.
7. Reynes, M., J. P. Aubert, J. H. Cohen, J. Audouin, V. Tricottet, J. Diebold, and M. D. Kazatchkine. 1985. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 135:2687.
8. Birkenbach, M.. X. Tong, L. E. Bradbury, T. F. Tedder, and E. Kieff. 1992. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J. Exp. Med. 176:1405.
9. Young, L. S., D. Clark, J. W. Sixbey, and A. B. Rickinson. 1986. Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1:240.
10. Reid, K. B. M., P. I. Bentley, R. D. Campell, L. P. Chung, R. B. Sim, T. Kristensen, and B. F. Tack. 1986. Complement system proteins which interact with C3b or C4b. Immunol. Today 7:230.
11. Reid, K. B. M., and A. J. Day. 1989. Structure-function relationship of the complement components. Immunol. Today 10:177.
12. Melchers, F., A. Erdei, T. Schulz, and M. P. Dierich. 1985. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317:264.
13. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407.
14. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.